The role of hemoglobin A1c as a predictor of major adverse cardiovascular events in patients with type 2 diabetes mellitus after percutaneous coronary intervention: a case-cohort study

The role of hemoglobin A1c as a predictor of major adverse cardiovascular events in patients with type 2 diabetes mellitus after percutaneous coronary intervention: a case-cohort study

Abstract Background Few studies have investigated the potential predictive value of glycosylated hemoglobin A (HbA1c) and clinical outcomes in diabetic patients after percutaneous coronary intervention (PCI), and the results of the reports have often been inconclusive and contradictory. We have orga...

Full description

Saved in:
Bibliographic Details
Main Authors: Babak Bagheri, Rozita Jalalian, Farima Sadat Mousavi, Soheil Azizi, Abbas Alipour, Fatemeh Mousavi, Erfan Ghadirzadeh
Format: Article
Language:English
Published: BMC 2024-10-01
Series:BMC Cardiovascular Disorders
Subjects:
Major adverse cardiovascular events
MACE
Percutaneous coronary intervention
Glycated hemoglobin
HbA1c
Diabetes mellitus
Online Access:https://doi.org/10.1186/s12872-024-04267-2
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12872-024-04267-2

Similar Items